NTI on 9 news Perth Tonight, page-8

In regards to endorsements, the AMA and Autism groups wont be on board quickly. These associations are very big businesses and they are hardly going to endorse any new treatments which may cannablise their own authority. These large organizations are very protective of their "TURF". Mente is the new kid on the block so don't expect any warm welcomes.
Success will be driven by continuous positive feedback from those who adopt the therapy and if reality reflects the trial results, then australia will be a very big market indeed.
Assume just a 10% uptake in australia (16000 people) x $1200 profit per item = $19M profit in australia, alone, which is a relatively small market compared to Europe and the US.